General Information
Version
10.0
Revision date
2014-10-27
Product name
CDP870
Product Synonyms
Cimzia
1.2.1 Relevant identified uses
Pegylated antibody fragment, which is available commercially and also being developed for use as a pharmaceutical product
Emergency telephone
+32 1 458 4545
Icons in SDS
Company Information
company name
UCB Pharma SA
e-mail address of the competent person responsible for the Safety Data Sheet
corporatehse@ucb.com
Section 2
SECTION 2: Hazards identification
Classification According to Directive 67/548/EEC or 1999/45/EC: Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
Please refer also to the "Generic Hazard Assessment for Antibodies-based Drugs" document
2.3 Other hazards
No additional information available
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Classification according to Directive 67/548/EEC or 1999/45/EC Not classified Adverse physicochemical, human health and environmental effects Please refer also to the "Generic Hazard Assessment for Antibodies-based Drugs" document.
